Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/dOpZCduTtWCefJlxCidawyCicNEYQJ
 | White Paper: Improving Total Cost of Ownership with EQMS
Companies are looking for ways to improve product quality, customer satisfaction and profitability while dealing with rising costs, competition and regulatory pressures. This white paper details how utilizing an EQMS backbone enables a broader organizational view of these issues, allowing for increased revenues and margins, operational efficiencies and global standardization for stakeholders. Read it now! | |
| Health Care & Policy |  |  | | - Subcutaneous Herceptin works as well as IV form in breast cancer
A randomized study found that a subcutaneous form of Genentech's Herceptin, or trastuzumab, showed pharmacokinetics and activity as good as IV delivery in patients with breast cancer who took the treatment before surgery. The two formulations attained 40% to 45% pathologic complete response. Researchers said non-inferiority indicates the subcutaneous form as a valid alternative to IV delivery. MedPage Today (free registration) (8/10)        | Earn 2X rewards points on advertising costs with The Business Gold Rewards Card from American Express OPEN. Designed to earn Membership Rewards® points faster:
• 3X points on airfare
• 2X points on advertising, gas, shipping
• 1X points on everything else
LEARN MORE AND APPLY |
  | Company & Financial News | | | | - Malaria vaccine project gets $2.5M NIAID grant
The National Institute of Allergy and Infectious Diseases awarded a $2.5 million, three-year grant to Antigen Discovery and Sanaria for their collaborative program to find Plasmodium falciparum antigens linked to malaria resistance. The research could lead to a test that predicts vaccine effectiveness in patients and improved vaccine development, according to Antigen Discovery. Genetic Engineering & Biotechnology News (8/13) | Global Developments | | | | - Researchers explore stem cells for joint conditions
Researchers at the University Health Network in Toronto are studying the potential of stem cells to create bone and cartilage for use as regenerative treatments of arthritis and possibly as an alternative to artificial hips and knees. Researchers also are looking at the potential of mesenchymal stem cells to restore damaged joints. National Post (Canada) (8/12)
| Food & Agriculture | | | | - NeoVentures explores compound spray for crop improvement
NeoVentures Biotechnology, in collaboration with Canada Bread, is developing a compound as a crop spray to improve the protein levels in wheat. A $106,000 Canadian grant was awarded to NeoVentures to help further the research and bring the product to market. The spray originated as an investigational treatment in California, according to NeoVentures CEO Gregory Penner. The London Free Press (Ontario) (8/13) | Industrial & Environmental | | | | - Vilsack: No need to alter RFS
 Agriculture Secretary Tom Vilsack reiterated his support for the Renewable Fuel Standard during a speech at a conference Friday. There is no need to tamper with the RFS because the market is already responding to drought-induced corn-price hikes, Vilsack said. "The market responds, the market reacts, the market pays attention, and we're already seeing that," he said. DomesticFuel.com (8/10) | News from BIO | | | | - Ship with FedEx
FedEx is now offering member companies discounts of up to 35% off select FedEx services, both U.S. and international services. The BIO program with FedEx is one of the many cost-savings programs offered by BIO through its Business Solutions program. There is no charge for BIO member companies to participate in any of the BIO Business Solutions programs -- it is a benefit of membership. Learn more about the BIO and FedEx program.
| SmartQuote | | | |  | Life leaps like a geyser for those who drill through the rock of inertia."
--Alexis Carrel,
French surgeon and biologist  |
| | This SmartBrief was created for jmabs1@gmail.com
| | | Read more at SmartBrief.com | | A powerful website for SmartBrief readers including: | | | | | | | | | | Recent BIO SmartBrief Issues: - Monday, August 13, 2012
- Friday, August 10, 2012
- Thursday, August 09, 2012
- Wednesday, August 08, 2012
- Tuesday, August 07, 2012
| | | Lead Editor: Tom Parks
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004 | | | | | | © 1999-2012 SmartBrief, Inc.® Legal Information |
|
No comments:
Post a Comment